Stay updated with breaking news from Yelin Jun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GC Biopharma (006280. KS) and Novel Pharma have announced that the U.S. FDA has cleared the investigational new drug (IND) application for their jointly developed MPSIIIA (Sanfilippo Syndrome Type A) treatment, GC1130A....
YONGIN, South Korea, May 7, 2024 /PRNewswire/ -- GC Genome Corporation, a leading diagnostics company, today announced that it will present the new clinical
/PRNewswire/ -- GC Biopharma Corp. (006280.KS) announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to its...
/PRNewswire/ -- GC Biopharma Corp (006280.KS) today announces that the US Food and Drug Administration (FDA) has approved ALYGLO (immune globulin intravenous,...
/PRNewswire/ -- GC Biopharma (006280.KS), a South Korean biopharmaceutical company (CEO, Eun-Chul Huh), announced on November 30th that it has completed the...